Major Salivary Gland Neoplasm — Trials

Major Salivary Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

46 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07812259	Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor(PAROCAINE)	recruiting	Early Phase 1	10	Centre Hospitalier Universitaire de NīmesOTHER	1	Sep 10, 2026	clinicaltrials
NCT05408845	Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers	recruiting	Phase 2	146	NRG OncologyOTHER	1	Aug 17, 2026	clinicaltrials
NCT01365169	Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"	recruiting	N/A	590	M.D. Anderson Cancer CenterOTHER	1	Jul 15, 2026

Data updated 20 days agoSource updated Sep 10, 2026source: clinicaltrials